Mycobacterium tuberculosis P-type ATPases: possible targets for drug or vaccine development.

ABSTRACT: Tuberculosis (TB) has been the biggest killer in the human history; currently, Mycobacterium tuberculosis (Mtb) kills nearly 2 million people each year worldwide. The high prevalence of TB obligates the identification of new therapeutic targets and the development of anti-TB vaccines that can control multidrug resistance and latent TB infections. Membrane proteins have recently been suggested as key targets for bacterial viability. Current studies have shown that mycobacteria P-type ATPases may play critical roles in ion homeostasis and in the response of mycobacteria to toxic substances in the intraphagosomal environment. In this review, we bring together the genomic, transcriptomic, and structural aspects of the P-type ATPases that are relevant during active and latent Mtb infections, wh

SUBMITTER: Novoa-Aponte L 

PROVIDER: S-EPMC4119724 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature